LIGHT-UP outcomes: GS200 patients lose on average 11% of body weight
Results from the LIGHT-UP clinical trial for adults with overweight or obesity who have prediabetes or type 2 diabetes and were treated...
LIGHT-UP outcomes: GS200 patients lose on average 11% of body weight
Gelesis announces merger with Capstar Special
Plenity induced weight loss results in NALFD fibrosis score improvement
Gelesis gains European approval for PLENITY weight loss treatment